PubRank

Michael W Cho

Author PubWeight™ 14.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies. Virology 2003 1.24
2 Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein. Virology 2004 1.17
3 Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cells. J Virol 2008 1.16
4 Human immunodeficiency virus type 1 envelope gp120-induced partial T-cell receptor signaling creates an F-actin-depleted zone in the virological synapse. J Virol 2009 1.14
5 Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol 2006 1.12
6 Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles. J Virol 2003 1.08
7 Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope. Virology 2007 1.07
8 Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. J Virol 2007 1.06
9 How can vaccines against influenza and other viral diseases be made more effective? PLoS Biol 2010 0.96
10 Structural characterization of HIV gp41 with the membrane-proximal external region. J Biol Chem 2010 0.95
11 HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA). PLoS One 2011 0.92
12 Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology 2006 0.85
13 Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry. Biochemistry 2010 0.84
14 Polyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody Responses. J Biomed Nanotechnol 2016 0.76